China's war on healthcare costs lures India's biggest drugmaker Sun Pharma

The policy push comes as many generic drugmakers are still reeling from a brutal price war in the world's biggest drug market, the US.

Sun Pharmaceutical Industries Ltd. is scouting for a partner in China to help it win a larger piece of the world’s second-largest drug market, where the government is on a mission to drive down healthcare costs.

With recovery underway in its US business, Sun Pharma’s billionaire founder Dilip Shanghvi is honing in on China and believes market watchers are underestimating the potential there for India’s largest drugmaker.

“There is a big opportunity for us,” Shanghvi said in an interview with Bloomberg News Editor-in-Chief John Micklethwait in Mumbai on Thursday. “That would create a significant new revenue stream, which is not